Article information
Full text is only aviable in PDF
Bibliografía
[1.]
T.F. Blaschke, K.L. Maimon.
Antihypertensive agents and the drug therapy of hypertension.
The pharmacological basis of therapeutics., 6.a, pp. 892-915
[2.]
J.A.D. Cooper Jr., D.A. White, R.A. Matthay.
Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs.
Am Rev Respir Dis, 133 (1986), pp. 488-505
[3.]
R.T. Bell, M. Lippmann.
Hydrochlorothiazide-induced pulmonary edema Report of a case and review of the literature.
Arch lntern Med, 139 (1979), pp. 817-819
[4.]
I.D. Levay.
Hydrochlorothiazide-induced pulmonary edema.
Drug Intell Clin Pharm, 18 (1984), pp. 238-239
[5.]
R.W. Carlson, R.C. Schaeffer Jr., V.K. Puri, A.P. Brennan, M.H. Weil.
Hypovolemia and permeability pulmonary edema associated with anaphylaxis.
Crit Care Med, 9 (1981), pp. 883-885
[6.]
C. Piper, D. Wallem, D. Wesche, N. Brattig, G.J. Diao, P.A. Berg.
Lungenoedem nach Einnahme von Hydrochlorothiazid Eine seltene, vital bedrohliche Nebenwirkung.
Dtsch Med Wochenschr, 108 (1983), pp. 1.480-1.483
[7.]
W.M. Alberts, G.R. Priest, K.M. Moser.
The Outlook for survivors of ARDS.
Chest, 84 (1983), pp. 272-274
[8.]
S. Lakshminarayan, R.E. Stanford, T.L. Petty.
Prognosis after recovery from adult respiratory distress syndrome.
Am Rev Respir Dis, 113 (1976), pp. 7-16
Copyright © 1988. Sociedad Española de Neumología y Cirugía Torácica
